Literature DB >> 18335846

Ibuprofen: a journey from prescription to over-the-counter use.

Nicholas Moore1.   

Abstract

Ibuprofen was the first non-aspirin non-steroidal antiinflammatory drug (NSAID) to be approved for over-the-counter (OTC) use and is widely considered to be the best tolerated drug of its class. Low-dose, OTC ibuprofen has been used for pain relief for over 30 years without any obvious major health issues. However, there is no clear differentiation between the OTC and prescription doses of ibuprofen, and their respective effects. Adverse reactions to ibuprofen appear to be dose and duration dependent, and this may be the reason for the observed tolerability of the drug at OTC doses. OTC ibuprofen is at least as effective as aspirin and more effective than paracetamol. The tolerability concerns associated with higher dose NSAIDs currently do not apply to low-dose, short-term use of ibuprofen for common pain. Ibuprofen is associated with the least risk of GI complications compared with other NSAIDs and is considered relatively benign in overdose. This review will aim to distinguish the safety of OTC or non-prescription use of ibuprofen from its prescription use.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18335846     DOI: 10.1177/014107680710004801s01

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


  5 in total

1.  Attitudes, attributions, and usage patterns of primary care patients with regard to over-the-counter drugs-a survey in Germany.

Authors:  Julian Wangler; Michael Jansky
Journal:  Wien Med Wochenschr       Date:  2022-09-23

2.  Palpitations following regular ibuprofen dosing in a 13-year-old girl: a case report.

Authors:  Robert J Douglas
Journal:  J Med Case Rep       Date:  2010-03-02

Review 3.  Ibuprofen: pharmacology, efficacy and safety.

Authors:  K D Rainsford
Journal:  Inflammopharmacology       Date:  2009-11-21       Impact factor: 4.473

Review 4.  Advanced Analgesic Drug Delivery and Nanobiotechnology.

Authors:  Nicoleta Stoicea; Juan Fiorda-Diaz; Nicholas Joseph; Muhammad Shabsigh; Carlos Arias-Morales; Alicia A Gonzalez-Zacarias; Ana Mavarez-Martinez; Stephen Marjoribanks; Sergio D Bergese
Journal:  Drugs       Date:  2017-07       Impact factor: 9.546

5.  In Vitro Evaluation of Smart and pH-Sensitive Chondroitin Sulfate/Sodium Polystyrene Sulfonate Hydrogels for Controlled Drug Delivery.

Authors:  Muhammad Suhail; I-Hui Chiu; Ming-Chia Hung; Quoc Lam Vu; I-Ling Lin; Pao-Chu Wu
Journal:  Gels       Date:  2022-06-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.